| Financial Year |
March 31 2023 |
| Monetary Funds |
875,257,796.07 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
653,935,117.44 |
| Accounts Receivable |
405,474,170.46 |
| Advances to Suppliers |
142,869,788.83 |
| Other Receivables |
38,942,576.62 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
1,020,000.00 |
| Inventories |
712,427,746.03 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,097,759.00 |
| Total Current Assets |
2,836,572,685.42 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
210,613,544.97 |
| Investment Properties |
7,711,777.83 |
| Fixed Assetes |
1,054,207,577.35 |
| Under-construction Projects |
60,198,568.92 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
100,901,430.97 |
| R&D expenses |
7,018.87 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,443,936.22 |
| Deferred Income Tax Assets |
27,531,315.42 |
| Other Non-Current Assets |
37,003,568.53 |
| Sub-Total of Non-Current Assets |
1,532,496,531.54 |
| Total Assets |
4,369,069,216.96 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
755,165,612.78 |
| Accounts Payable |
761,751,169.85 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
33,624,571.52 |
| Taxes Payable |
11,299,161.33 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
33,380,414.95 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
11,414,662.55 |
| Other Current Liabilities |
270,957.07 |
| Sub-Total of Current Liabilities |
1,825,939,195.70 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,858,183.31 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,229,605.22 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
40,594,011.07 |
| Total Liabilities |
1,866,533,206.77 |
| Paid-In Capital(Or Share Stock) |
508,760,826.00 |
| Capital Surplus |
1,354,816,870.80 |
| Surplus Reserve |
64,080,760.90 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
569,090,366.91 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,502,536,010.19 |
| Owner's Equity（Stockholder's Equity） |
2,502,536,010.19 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,369,069,216.96 |
